BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G Report for Inhibrx Biosciences, Inc. Common Stock (INBX)

Filing Manager
BlackRock, Inc.
Reporting Manager
BlackRock, Inc.
Symbol
INBX
Shares outstanding
14,593,105 shares
Disclosed Ownership
831,807 shares
Ownership
5.7%
Form type
SCHEDULE 13G
Filing time
04 Feb 2025, 15:45:44 UTC
Date of event
31 Dec 2024
Next filing
17 Oct 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BlackRock, Inc. 5.7% 831,807 822,613 0 Spencer Fleming Managing Director